Search Results - "Raschke, Marian"

Refine Results
  1. 1

    Translating in vitro to in vivo and animal to human by Steger-Hartmann, Thomas, Raschke, Marian

    Published in Current opinion in toxicology (01-10-2020)
    “…This review summarizes the recent advances in the field of investigative toxicology with a particular focus on the toxicological endpoint drug-induced liver…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Differentiation of Aneugens and Clastogens in the In Vitro Micronucleus Test by Kinetochore Scoring Using Automated Image Analysis by Wilde, Sabrina, Queisser, Nina, Holz, Christian, Raschke, Marian, Sutter, Andreas

    Published in Environmental and molecular mutagenesis (01-04-2019)
    “…The in vitro micronucleus test according to OECD Test Guideline 487 (TG 487) is widely used to investigate the genotoxic potential of drugs. Besides the…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Quantitative Systems Toxicology Identifies Independent Mechanisms for Hepatotoxicity and Bilirubin Elevations Due to AKR1C3 Inhibitor BAY1128688 by Battista, Christina, Shoda, Lisl K.M., Watkins, Paul B., Groettrup‐Wolfers, Esther, Rottmann, Antje, Raschke, Marian, Generaux, Grant T.

    Published in Clinical pharmacology and therapeutics (01-11-2023)
    “…BAY1128688 is a selective inhibitor of AKR1C3, investigated recently in a trial that was prematurely terminated due to drug‐induced liver injury. These…”
    Get full text
    Journal Article
  6. 6

    A tripartite mode of action approach for investigating the impact of aneugens on tubulin polymerization by Stock, Valerie, Sutter, Andreas, Raschke, Marian, Queisser, Nina, Gollapudi, B.

    Published in Environmental and molecular mutagenesis (01-04-2018)
    “…Chemical‐induced disruption of the cellular microtubule network is one key mechanism of aneugenicity. Since recent data indicate that genotoxic effects of…”
    Get full text
    Journal Article
  7. 7
  8. 8
  9. 9

    A microfluidic thyroid-liver platform to assess chemical safety in humans by Kühnlenz, Julia, Karwelat, Diana, Steger-Hartmann, Thomas, Raschke, Marian, Bauer, Sophie, Vural, Özlem, Marx, Uwe, Tinwell, Helen, Bars, Remi

    Published in ALTEX (01-01-2023)
    “…Thyroid hormones (THs) are crucial regulators of human metabolism and early development. During the safety assessment of plant protection products, the human…”
    Get full text
    Journal Article
  10. 10
  11. 11

    A rodent thyroid-liver chip to capture thyroid toxicity on organ function level by Karwelat, Diana, Kühnlenz, Julia, Steger-Hartmann, Thomas, Bars, Remi, Tinwell, Helen, Marx, Uwe, Bauer, Sophie, Born, Oliver, Raschke, Marian

    Published in ALTEX (2023)
    “…Endocrine disruption by environmental chemicals continues to be a concern for human safety. The rat, a widely used model organism in toxicology, is very…”
    Get full text
    Journal Article
  12. 12
  13. 13
  14. 14
  15. 15

    A statistical approach for analyzing data from the in vivo Pig-a gene mutation assay by Igl, Bernd-Wolfgang, Dertinger, Stephen D., Dobrovolsky, Vasily N., Raschke, Marian, Sutter, Andreas, Vonk, Richardus

    “…•The proposed statistical model uses both treatment and longitudinal information.•Treatment and longitudinal effects can be determined within and between…”
    Get full text
    Journal Article
  16. 16

    Best practices for application of attachment cells to in vitro micronucleus assessment by flow cytometry by Bemis, Jeffrey C., Bryce, Steven M., Nern, Marlies, Raschke, Marian, Sutter, Andreas

    “…•We provide best practices information for the conduct of the in vitro micronucleus assay.•The information covers cell handling, exposure, processing,…”
    Get full text
    Journal Article
  17. 17

    Comparison of the Mesoscale Discovery and Luminex multiplex platforms for measurement of urinary biomarkers in a cisplatin rat kidney injury model by Pavkovic, Mira, Riefke, Björn, Gutberlet, Katrin, Raschke, Marian, Ellinger-Ziegelbauer, Heidrun

    “…In the past years several new urinary nephrotoxicity biomarkers have been qualified for use in preclinical studies by the FDA and EMA. Subsequently, kits have…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Abstract 1163: Phosphoserine aminotransferase 1 (PSAT1) as a novel anti-tumor target in hepatocellular carcinoma by Ding, Zhaobing, Wee, Kenneth, Kim, Eung-Sam, Samanta, Animesh, Steckel, Michael, Raschke, Marian, Velan, Sendhil, Chang, Young-Tae, Haegebarth, Andrea, Ziegelbauer, Karl, Gruenewald, Sylvia, Han, Weiping

    Published in Cancer research (Chicago, Ill.) (01-08-2015)
    “…Abstract With an estimated 700,000 new cases per year, hepatocellular carcinoma (HCC) represents the fifth commonest cancer and is the third leading cause of…”
    Get full text
    Journal Article
  20. 20

    The Role of Residual Gadolinium in the Induction of Nephrogenic Systemic Fibrosis-Like Skin Lesions in Rats by Pietsch, Hubertus, Raschke, Marian, Ellinger-Ziegelbauer, Heidrun, Jost, Gregor, Walter, Jakob, Frenzel, Thomas, Lenhard, Diana, Hütter, Joachim, Sieber, Martin A

    Published in Investigative radiology (01-01-2011)
    “…OBJECTIVE:Nephrogenic systemic fibrosis (NSF) is an acquired, idiopathic disorder. Most of the cases are observed in patients with end stage renal disease…”
    Get full text
    Journal Article